Gene Test Identifies Breast Cancer Patients Who Can Safely Skip Chemotherapy
Findings from the OPTIMA trial show that the Prosigna test identifies patients who can safely skip chemotherapy and use hormone therapy alone.
Read More
Search Results for: liver disease
Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers
The initiative aims to standardize digital pathology through an open-source platform and image management system.
Read More
New AI Test Predicts Mortality Risk in Metastatic Prostate Cancer
The digital pathology platform provides patient-specific risk estimates to help clinicians tailor treatment for metastatic hormone-sensitive disease.
Read More
FDA Clears New Automated Blood Culture System for Faster Sepsis Detection
The BD BACTEC FXI Culture System reduces detection time for bloodstream infections by approximately three hours compared to previous models.
Read More
Multi-Cancer Blood Test Reduces Stage IV Diagnoses in Large Clinical Trial
Results from the NHS-Galleri study show a 26% reduction in metastatic cancer diagnoses by the third round of screening.
Read More